Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti - 26(2013), 1 vom: 13., Seite 55-7 |
| Sprache: |
Tschechisch |
|---|
| Weiterer Titel: |
Dalsí linie cílené lécby u nemocných s metastatickým renálním karcinomem s progresí na lécbe pazopanibem: expertní stanovoska Ceské kooperativné skupiny pro metastatický renální karcinom |
|---|
| Beteiligte Personen: |
Büchler, T [VerfasserIn] |
|---|
| Themen: |
7RN5DR86CK |
|---|
| Anmerkungen: |
Date Completed 19.09.2013 Date Revised 03.12.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM226880621 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM226880621 | ||
| 003 | DE-627 | ||
| 005 | 20231224072423.0 | ||
| 007 | tu | ||
| 008 | 231224s2013 xx ||||| 00| ||cze c | ||
| 028 | 5 | 2 | |a pubmed24n0756.xml |
| 035 | |a (DE-627)NLM226880621 | ||
| 035 | |a (NLM)23607143 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a cze | ||
| 100 | 1 | |a Büchler, T |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Another approach to targeted therapy of patients with metastatic renal carcinoma with progression in treatment with pazopanib:expert assessment by the Czech Cooperative Group for Metastatic Renal Carcinoma |
| 246 | 3 | 3 | |a Dalsí linie cílené lécby u nemocných s metastatickým renálním karcinomem s progresí na lécbe pazopanibem: expertní stanovoska Ceské kooperativné skupiny pro metastatický renální karcinom |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 19.09.2013 | ||
| 500 | |a Date Revised 03.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 7 | |a Angiogenesis Inhibitors |2 NLM | |
| 650 | 7 | |a Indazoles |2 NLM | |
| 650 | 7 | |a Pyrimidines |2 NLM | |
| 650 | 7 | |a Sulfonamides |2 NLM | |
| 650 | 7 | |a pazopanib |2 NLM | |
| 650 | 7 | |a 7RN5DR86CK |2 NLM | |
| 650 | 7 | |a Receptors, Vascular Endothelial Growth Factor |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Finek, J |e verfasserin |4 aut | |
| 700 | 1 | |a Hájek, J |e verfasserin |4 aut | |
| 700 | 1 | |a Kocák, I |e verfasserin |4 aut | |
| 700 | 1 | |a Kubácková, K |e verfasserin |4 aut | |
| 700 | 1 | |a Lakomý, R |e verfasserin |4 aut | |
| 700 | 1 | |a Melichar, B |e verfasserin |4 aut | |
| 700 | 1 | |a Petruzelka, L |e verfasserin |4 aut | |
| 700 | 1 | |a Poprach, A |e verfasserin |4 aut | |
| 700 | 1 | |a Siffnerová, M |e verfasserin |4 aut | |
| 700 | 1 | |a Tomásek, J |e verfasserin |4 aut | |
| 700 | 1 | |a Vyzula, R |e verfasserin |4 aut | |
| 700 | 1 | |a Zemanová, M |e verfasserin |4 aut | |
| 700 | 0 | |a Cezkou Kooperativní Skupinu pro Metastický Renální Karcinom |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti |d 1998 |g 26(2013), 1 vom: 13., Seite 55-7 |w (DE-627)NLM09368763X |x 1802-5307 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2013 |g number:1 |g day:13 |g pages:55-7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2013 |e 1 |b 13 |h 55-7 | ||